Entrada Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	78.05	67.6	45.16	291.06	39.05	16.84
Short-Term Investments	371.3	284.37	143.56	-	-	-
Cash & Short-Term Investments	449.34	351.97	188.71	291.06	39.05	16.84
Cash Growth	27.08%	86.51%	-35.16%	645.46%	131.80%	-
Accounts Receivable	2.6	5.88	-	-	-	-
Other Receivables	-	1.7	0.6	-	-	-
Receivables	2.6	7.58	0.6	-	-	-
Prepaid Expenses	13.39	9.92	20.56	7.64	0.9	0.59
Other Current Assets	-	0.3	-	-	-	-
Total Current Assets	465.34	369.77	209.88	298.7	39.95	17.44
Property, Plant & Equipment	84.56	92.68	33.02	6.26	3.04	0.8
Other Long-Term Assets	4.7	6.74	9.16	0.87	0.54	-
Total Assets	554.59	469.19	252.06	305.83	43.53	18.24
Accounts Payable	1.29	3.28	5.99	0.71	1.6	0.71
Accrued Expenses	13.4	10.32	7.15	5.53	1.64	0.99
Current Portion of Leases	7.74	7.91	8.41	-	-	-
Current Income Taxes Payable	2.25	4.02	-	-	-	-
Current Unearned Revenue	45.92	132.26	-	-	-	-
Other Current Liabilities	-	1	0.43	0.49	0.12	0.22
Total Current Liabilities	70.6	158.8	21.97	6.72	3.36	1.92
Long-Term Leases	53.58	60.32	17.53	-	-	-
Long-Term Unearned Revenue	7.96	7.72	-	-	-	-
Other Long-Term Liabilities	-	-	-	0.4	-	0.02
Total Liabilities	132.14	226.83	39.5	7.12	3.36	1.94
Common Stock	0	0	0	0	-	0
Additional Paid-In Capital	551.95	437.13	402.89	392.38	1.02	0.47
Retained Earnings	-130.48	-194.97	-188.29	-93.67	-42.51	-15.99
Comprehensive Income & Other	0.97	0.2	-2.06	-	-	-
Total Common Equity	422.45	242.36	212.55	298.72	-41.49	-15.52
Shareholders' Equity	422.45	242.36	212.55	298.72	40.17	16.3
Total Liabilities & Equity	554.59	469.19	252.06	305.83	43.53	18.24
Total Debt	61.31	68.23	25.94	-	-	-
Net Cash (Debt)	388.03	283.74	162.78	291.06	39.05	16.84
Net Cash Growth	36.39%	74.31%	-44.08%	645.46%	131.80%	-
Net Cash Per Share	10.92	8.59	5.20	46.44	35.33	18.05
Filing Date Shares Outstanding	37.42	32.33	33.08	31.25	1.41	0.93
Total Common Shares Outstanding	37.4	32.17	31.39	31.22	1.24	0.93
Working Capital	394.73	210.98	187.9	291.98	36.59	15.52
Book Value Per Share	11.30	7.53	6.77	9.57	-33.35	-16.63
Tangible Book Value	422.45	242.36	212.55	298.72	-41.49	-15.52
Tangible Book Value Per Share	11.30	7.53	6.77	9.57	-33.35	-16.63
Machinery	-	15.26	8.54	6.12	2.16	0.85
Construction In Progress	-	-	0.58	-	-	-
Leasehold Improvements	-	1.86	1.86	1.56	1.25	0.07

Source: S&P Capital IQ. Standard template. Financial Sources.